Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kynurenic acid blocks chemogenic nociception.

M Hajós1, G Engberg

  • 1Department of Physiology, A. Szent-Györgyi Medical University, Szeged, Hungary.

The Journal of Pharmacy and Pharmacology
|May 1, 1990
PubMed
Summary

Excitatory amino acids (EAA) play a role in pain perception. This study found that kynurenic acid, but not MK-801, blocked capsaicin-induced eye wiping, suggesting EAA activate non-NMDA receptors in pain transmission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.

Schizophrenia research·2019
Same author

Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.

Acta psychiatrica Scandinavica·2018
Same author

LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning.

Journal of neuroimmunology·2017
Same author

CSF GABA is reduced in first-episode psychosis and associates to symptom severity.

Molecular psychiatry·2017
Same author

Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

Neurochemical research·2016
Same author

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.

Molecular psychiatry·2015

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Excitatory amino acids (EAA) are implicated in nociception.
  • Understanding the specific receptors involved in pain pathways is crucial for developing targeted analgesics.

Purpose of the Study:

  • To investigate the role of excitatory amino acid receptors in capsaicin-induced nociception.
  • To determine the efficacy of different EAA receptor antagonists in blocking chemogenic pain responses.

Main Methods:

  • Capsaicin was used to induce eye wiping responses in a study model.
  • Two EAA receptor antagonists, kynurenic acid and MK-801, were administered via different routes (intracisternal and intravenous).
  • The blockade of capsaicin-induced eye wiping by the antagonists was measured.

Main Results:

  • Intracisternally administered kynurenic acid significantly blocked capsaicin-induced eye wiping.
  • Intravenously administered MK-801 did not effectively block the induced eye wiping.
  • These findings suggest a differential role for EAA receptor subtypes in this pain model.

Conclusions:

  • Excitatory amino acids, likely via non-NMDA receptors, are involved in transmitting chemogenic nociception.
  • Kynurenic acid demonstrates potential as a therapeutic agent for specific types of pain.
  • The route of administration and specific receptor antagonism are critical factors in modulating pain responses.

Related Experiment Videos